Johnson & Johnson Seeks F.D.A. Approval for Covid Booster

The company said that a second shot of its vaccine about two months after the first significantly boosts protection to 94 percent against moderate to severe disease.

source https://www.nytimes.com/2021/10/05/world/johnson-covid-vaccine-booster-fda.html

Post a Comment

0 Comments